Blood Cancer & Bone Marrow Transplant in India for Tanzanian Patients — Complete Guide 2025

Complete guide to blood cancer and bone marrow transplant in India for Tanzanian patients. Leukaemia, lymphoma, myeloma, CAR-T therapy, BMT costs in USD and best hospitals. Free consultation.

Blood Cancer & Bone Marrow Transplant in India: What Tanzanian Patients Need to Know

Blood cancers — leukaemia, lymphoma, and multiple myeloma — are among the most serious and complex cancers diagnosed in Tanzania. They are also among the most treatable when managed by specialist haematological oncologists using modern protocols.

The fundamental problem for Tanzanian patients is that specialist haematology oncology care — bone marrow transplant units, CAR-T cell therapy, advanced targeted treatments — simply does not exist within the country. Patients who need these treatments have no option but to travel.

India has become the most accessible and affordable destination in the world for blood cancer treatment and bone marrow transplant. This guide covers every treatment option, real costs in USD, the best hospitals for haematological cancers, and exactly how to get started from Tanzania.

For a complete overview of the entire journey from Tanzania to India for cancer treatment — including visa steps, logistics, and total budget planning — visit our full guide on [cancer treatment in India for Tanzania](https://treatcancerinindia.com/cancer-treatment-india-for-tanzania).

---

Types of Blood Cancer Treated in India

Leukaemia

Leukaemia is a cancer of the blood and bone marrow characterised by the overproduction of abnormal white blood cells. The main types treated at Indian hospitals include:

Acute Myeloid Leukaemia (AML)

A fast-growing leukaemia requiring urgent treatment. Standard treatment is intensive induction chemotherapy followed by consolidation — either further chemotherapy or bone marrow transplant depending on risk category and response.

Acute Lymphoblastic Leukaemia (ALL)

More common in children but also affects adults. Treatment involves intensive multi-drug chemotherapy over 2–3 years. Bone marrow transplant is recommended for high-risk cases. India's hospitals have excellent outcomes for ALL — particularly in children.

Chronic Myeloid Leukaemia (CML)

A slower-growing leukaemia driven by the BCR-ABL gene mutation. Treated with targeted oral drugs called tyrosine kinase inhibitors (TKIs) — Imatinib, Dasatinib, Nilotinib. These drugs are available in India as affordable generics, making CML one of the most cost-effective blood cancers to treat in India long-term.

Chronic Lymphocytic Leukaemia (CLL)

A slow-growing leukaemia most common in older adults. Treatment ranges from active monitoring to targeted therapy with drugs like Ibrutinib, Venetoclax, and Rituximab — all available in India at significantly lower cost than in Western countries.

Lymphoma

Lymphoma is a cancer of the lymphatic system. There are two main categories:

Hodgkin Lymphoma

One of the most curable cancers when treated correctly. Standard treatment is combination chemotherapy (ABVD protocol) with or without radiation. Cure rates exceed 85–90% in early stage disease at India's top hospitals.

Non-Hodgkin Lymphoma (NHL)

A diverse group of lymphomas with varying behaviour and treatment approaches. Common subtypes include Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Mantle Cell Lymphoma, and Burkitt Lymphoma. Treatment involves chemotherapy, targeted therapy with Rituximab, and in relapsed cases, bone marrow transplant or CAR-T therapy.

Multiple Myeloma

Multiple myeloma is a cancer of plasma cells in the bone marrow. It causes bone pain, anaemia, kidney problems, and increased infection risk. Modern treatment in India includes:

• Induction chemotherapy — typically VRd (Bortezomib, Lenalidomide, Dexamethasone) or similar triplet regimens
• Autologous stem cell transplant — the standard consolidation after induction in eligible patients
• Maintenance therapy — Lenalidomide or Bortezomib to keep the disease under control long-term
• Novel agents — Daratumumab, Carfilzomib, Pomalidomide for relapsed or refractory disease

All of these drugs and procedures are available in India at a fraction of their cost in the West.

Myelodysplastic Syndromes (MDS)

MDS are a group of conditions where the bone marrow does not produce enough healthy blood cells. They range from low-risk forms managed with supportive care to high-risk forms that transform into AML. Bone marrow transplant is the only curative option for high-risk MDS and is performed at leading Indian haematology centres.

---

Bone Marrow Transplant in India: A Complete Guide

Bone marrow transplant — more accurately called haematopoietic stem cell transplant (HSCT) — is the most intensive treatment in haematology oncology. It involves replacing diseased bone marrow with healthy stem cells, either from the patient themselves or from a donor.

India performs thousands of bone marrow transplants every year and is the most affordable country in the world offering this procedure at internationally accredited hospitals.

Types of Bone Marrow Transplant

Autologous Transplant (Auto-SCT)

The patient's own stem cells are collected, stored, and reinfused after high-dose chemotherapy destroys the diseased marrow. Used in multiple myeloma, Hodgkin lymphoma, and some NHL cases.

• No donor matching required
• Lower risk of graft-versus-host disease
• Shorter hospital stay
• Cost in India: $18,000 – $25,000

Allogeneic Transplant (Allo-SCT)

Stem cells from a matched donor — sibling, unrelated donor, or cord blood — replace the patient's diseased marrow. Used in leukaemia, high-risk MDS, and some lymphoma cases.

• Requires donor matching (HLA typing)
• Graft-versus-tumour effect can eliminate residual disease
• More complex with higher risk of complications
• Longer hospital stay (4–6 weeks minimum)
• Cost in India: $25,000 – $40,000

Haploidentical Transplant (Half-Matched)

Uses a partially matched donor — typically a parent, child, or sibling — when a fully matched donor is not available. Has made transplant accessible to patients who previously had no donor option.

• Available at leading Indian transplant centres
• Cost in India: $28,000 – $45,000

The Bone Marrow Transplant Process: What to Expect

Understanding the timeline helps patients and families plan their trip accurately.

Phase 1 — Pre-transplant evaluation (1–2 weeks)

Comprehensive assessment of the patient's fitness for transplant: blood tests, organ function tests, bone marrow biopsy, infectious disease screening, cardiac and lung evaluation.

Phase 2 — Donor search and HLA typing (for allogeneic transplant)

Blood samples from the patient and potential donors (family members) are sent for HLA typing. Results take 1–2 weeks. If no family match is found, a search of international donor registries is initiated — this can take 4–8 weeks.

Phase 3 — Conditioning (1–2 weeks)

High-dose chemotherapy and/or radiation is given to destroy the patient's existing bone marrow and immune system, creating space for the new stem cells.

Phase 4 — Transplant day

The stem cells are infused intravenously — a relatively straightforward procedure that takes a few hours. The stem cells travel to the bone marrow and begin engrafting.

Phase 5 — Engraftment and early recovery (2–4 weeks in hospital)

This is the most critical phase. The patient is in a sterile BMT unit, closely monitored for infections, graft-versus-host disease (for allogeneic transplants), and other complications. Engraftment — when the new marrow begins producing blood cells — typically occurs 10–21 days after transplant.

Phase 6 — Early post-transplant monitoring (4–8 weeks near the hospital)

After discharge from the BMT unit, patients must remain close to the hospital for frequent monitoring. Most transplant centres require patients to stay within 30–60 minutes of the hospital for at least 4–6 weeks post-discharge.

Total time in India for bone marrow transplant: 10–16 weeks minimum for allogeneic transplant, 6–10 weeks for autologous transplant.

---

CAR-T Cell Therapy in India

CAR-T (Chimeric Antigen Receptor T-cell) therapy is one of the most revolutionary advances in cancer treatment in the past decade. It involves engineering a patient's own immune cells to recognise and destroy cancer cells — and has produced remarkable results in relapsed and refractory blood cancers that have failed all other treatments.

CAR-T therapy is now available in India — the first country in Asia outside of China to offer domestically manufactured CAR-T cells at an accessible price point.

Cancers treated with CAR-T in India:

• Relapsed/refractory Diffuse Large B-Cell Lymphoma (DLBCL)
• Relapsed/refractory ALL in children and young adults
• Relapsed/refractory multiple myeloma (newer CAR-T products)

Cost of CAR-T therapy in India: $40,000 – $60,000

This compares to $400,000–$500,000 in the USA, making India the only realistic option for Tanzanian patients who need this treatment.

---

Targeted and Immunotherapy Drugs for Blood Cancer in India

One of the greatest advantages of treating blood cancers in India is access to highly effective targeted drugs at dramatically lower cost. Many of these drugs are unavailable or completely unaffordable in Tanzania.

| Drug | Used For | Cost Per Month in India (USD) | Cost Per Month in USA (USD) |

|---|---|---|---|

| Imatinib (generic) | CML | $30 – $80 | $3,000 – $5,000 |

| Dasatinib | CML, ALL | $100 – $200 | $4,000 – $8,000 |

| Ibrutinib | CLL, Mantle Cell Lymphoma | $200 – $500 | $8,000 – $15,000 |

| Venetoclax | CLL, AML | $300 – $700 | $10,000 – $18,000 |

| Rituximab | NHL, CLL | $200 – $600 per infusion | $3,000 – $8,000 per infusion |

| Bortezomib | Multiple Myeloma | $300 – $700 per cycle | $5,000 – $10,000 per cycle |

| Lenalidomide | Multiple Myeloma | $100 – $300 per month | $15,000 – $20,000 per month |

| Daratumumab | Multiple Myeloma | $500 – $1,200 per infusion | $8,000 – $15,000 per infusion |

For Tanzanian patients with CML in particular, India represents a life-changing option — Imatinib, which must be taken daily indefinitely, costs as little as $30–$80 per month in India compared to thousands of dollars in the West. Many patients travel to India specifically to obtain a supply of this drug alongside their treatment.

---

Cost of Blood Cancer Treatment in India: Full Summary

| Treatment | Cost in India (USD) | Cost in USA (USD) | Savings |

|---|---|---|---|

| Chemotherapy per cycle (ABVD, R-CHOP etc.) | $400 – $1,500 | $5,000 – $15,000 | ~85% |

| Autologous bone marrow transplant | $18,000 – $25,000 | $150,000 – $250,000 | ~88% |

| Allogeneic bone marrow transplant | $25,000 – $40,000 | $200,000 – $400,000 | ~88% |

| Haploidentical transplant | $28,000 – $45,000 | $250,000 – $400,000 | ~88% |

| CAR-T cell therapy | $40,000 – $60,000 | $400,000 – $500,000 | ~88% |

| Radiation therapy (lymphoma) | $3,000 – $6,000 | $40,000 – $80,000 | ~92% |

| HLA typing (donor matching) | $300 – $600 | $3,000 – $6,000 | ~90% |

---

Sample All-Inclusive Trip Budget: Autologous BMT in India

| Expense | Estimated Cost (USD) |

|---|---|

| Return flights (DAR to Mumbai/Delhi) | $700 – $1,200 |

| e-Medical Visa (patient + attendant) | $50 – $100 |

| Accommodation near hospital (10 weeks) | $1,500 – $3,000 |

| Food and daily expenses (10 weeks) | $700 – $1,400 |

| Autologous bone marrow transplant | $18,000 – $25,000 |

| Pre-transplant diagnostic workup | $800 – $1,500 |

| Medicines and pharmacy | $500 – $1,200 |

| Local transport | $200 – $400 |

| Contingency buffer (15%) | $3,000 – $5,000 |

| Total estimate | $25,450 – $38,800 |

For a full breakdown of how to plan and reduce your total costs for blood cancer treatment in India from Tanzania, including accommodation options near BMT centres and how to manage long stays, visit our complete guide on [cancer treatment in India for Tanzanian patients](https://treatcancerinindia.com/cancer-treatment-india-for-tanzania).

---

Best Hospitals in India for Blood Cancer and Bone Marrow Transplant

Tata Memorial Hospital, Mumbai

India's foremost cancer institution has one of Asia's largest and most experienced BMT programmes. Tata Memorial performs hundreds of transplants every year across all types — autologous, allogeneic, and haploidentical. Their haematology oncology department is world-class and costs are significantly lower than private hospitals.

Best for: All blood cancer types, complex and high-risk cases, tightest budgets, ALL in children

Apollo Cancer Centre, Delhi and Chennai

Apollo has dedicated BMT units at both their Delhi and Chennai hospitals with strong international patient programmes. Their haematology teams are experienced in treating East African patients and the support infrastructure for travelling families is excellent.

Best for: Full-service blood cancer care, strong international patient support, all transplant types

Fortis Memorial Research Institute, Gurgaon

Fortis FMRI has a highly regarded haematology and BMT centre, particularly strong in allogeneic and haploidentical transplants. Their facility in Gurgaon is modern, well-equipped, and 30 minutes from Delhi's international airport.

Best for: Allogeneic and haploidentical transplant, advanced NHL, CLL

Medanta — The Medicity, Gurgaon

Medanta's Institute of Haematology and Blood Cancer is one of India's most advanced blood cancer centres. It offers CAR-T cell therapy, the full range of transplant types, and access to clinical trials for relapsed and refractory blood cancers.

Best for: CAR-T cell therapy, relapsed/refractory blood cancers, clinical trial access

AIIMS Delhi

AIIMS has one of India's oldest and most experienced haematology departments. Costs are the lowest available for this level of expertise. Particularly strong in leukaemia management and allogeneic transplant.

Best for: Lowest costs, leukaemia, academic expertise

Christian Medical College (CMC), Vellore

CMC Vellore is one of India's most respected medical institutions and has a long history in haematology and bone marrow transplant. It is particularly experienced in treating patients from Africa and has a compassionate approach to cost management for international patients in financial difficulty.

Best for: Ethical care, experienced Africa patient programme, allogeneic transplant, tighter budgets

---

Special Considerations for Tanzanian Blood Cancer Patients

Urgency of treatment

Acute leukaemias — AML and ALL — are medical emergencies. If you or a family member has been diagnosed with acute leukaemia, do not delay. Contact our team today and we will prioritise getting you to India as quickly as possible. Treatment delay in acute leukaemia significantly worsens outcomes.

Travelling with active blood cancer

Many blood cancer patients are anaemic, have low platelets, or are immunocompromised at the time of travel. Your Indian hospital will advise on whether it is safe to fly in your current condition and may recommend precautions such as blood transfusion before travel, wearing a mask on the flight, or arranging wheelchair assistance.

Family donors for allogeneic transplant

If an allogeneic transplant is recommended, a sibling is the most likely match. Bring 2–3 potential family donors with you to India — their HLA typing can be done in India within 1–2 weeks. If no family match is found, international donor registries will be searched, which takes longer and adds cost.

Long-term follow-up after transplant

After returning to Tanzania following a bone marrow transplant, regular blood tests and follow-up are required. Your Indian hospital will provide a detailed follow-up schedule and can interpret results sent remotely by email. Most routine follow-up blood tests can be performed in Tanzania, with results emailed to your Indian oncologist for review.

Children with blood cancer

India's hospitals have excellent paediatric haematology oncology programmes. Tata Memorial, Apollo, and CMC Vellore are particularly experienced in treating children with leukaemia and lymphoma. A parent or guardian must accompany the child — both can travel on appropriate visa categories.

---

How to Get Started From Tanzania

For a complete step-by-step guide to the entire process from Tanzania to India, including visa application, flights, accommodation near BMT centres, and what to bring, see our full resource on [cancer treatment in India for Tanzania](https://treatcancerinindia.com/cancer-treatment-india-for-tanzania).

Contact our Tanzania patient desk today for a free consultation. No cost, no obligation — and for acute cases, we prioritise same-day responses.

---

Frequently Asked Questions

Is bone marrow transplant available anywhere in Tanzania?

No. Bone marrow transplant is not currently available in Tanzania. Patients who need this procedure must travel abroad — and India offers the best combination of quality, expertise, and affordability in the world for this treatment.

How do I know if I need a bone marrow transplant?

Your haematologist will recommend a transplant based on your specific diagnosis, risk category, and response to initial chemotherapy. Not all blood cancer patients need a transplant — many leukaemias and lymphomas are cured with chemotherapy alone. An Indian specialist can review your case and give a clear recommendation.

Can I find a bone marrow donor in Tanzania?

HLA typing can be done in Tanzania at some reference laboratories, but the results need to be interpreted by a transplant specialist. If no family match is found, searching international donor registries is done through the transplant centre in India — this is included in the transplant coordination process.

How long does a bone marrow transplant take from start to finish?

Autologous transplant: 6–10 weeks in India. Allogeneic transplant: 10–16 weeks in India minimum, with the possibility of complications extending the stay. Your transplant team will give you a personalised estimate after your pre-transplant evaluation.

What is the success rate of bone marrow transplant in India?

Success rates vary by diagnosis, stage, age, and transplant type. At India's leading centres, overall survival rates are comparable to transplant centres in the USA and Europe. For example, autologous transplant for multiple myeloma achieves excellent outcomes with progression-free survival of 3–5 years or more in many patients. Your doctor will give you realistic outcome data specific to your case.

My child has been diagnosed with leukaemia in Tanzania. What should I do?

Contact us immediately. Acute leukaemia in children is a medical emergency but is also one of the most curable cancers in the world when treated promptly by specialists. We will connect you with a paediatric haematology oncology team in India within 24 hours. Do not wait.